I-Mab ADR (IMAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IMAB | VNDA | RCKT | ||
| Company | I-Mab ADR | Vanda Pharmaceuticals | Rocket Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.70 | 6.76 | 3.49 | ||
| High | 4.77 | 6.94 | 3.63 | ||
| Low | 4.49 | 6.59 | 3.43 | ||
| Latest | 4.63 | 6.91 | 3.58 | ||
| Change | -0.01 | +0.26 | +0.13 | ||
| % Change | -0.22% | +3.91% | +3.92% | ||
| Volume | 1,517,300 | 1,463,000 | 4,467,200 | ||
| 20-Day Average Volume | 2,165,250 | 2,073,975 | 5,230,695 | ||
| Previous Close | 4.64 | 6.65 | 3.44 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.00 | 8.00 | 4.51 | ||
| 20-Day Raw Stochastic | 25.00% | 10.09% | 9.66% | ||
| 20-Day Relative Strength | 50.83 | 44.10 | 42.29 | ||
| Weighted Alpha | +111.30 | +16.49 | +12.77 | ||
| Today's Opinion | 80% Buy | 40% Buy | 24% Buy | ||
| Previous Opinion | 80% Buy | 40% Buy | 8% Buy | ||
| Last Month's Opinion | 72% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.94% since 10/22/25 | +1.32% since 03/24/26 | -16.16% since 03/24/26 | ||
| Low | 4.13 on 10/24/25 | 6.57 on 03/30/26 | 3.38 on 03/30/26 | ||
| High | 4.88 on 10/28/25 | 7.27 on 03/25/26 | 5.14 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | +35.38% since 09/29/25 | -22.45% since 02/27/26 | -28.54% since 02/27/26 | ||
| Low | 3.46 on 09/30/25 | 6.57 on 03/30/26 | 3.38 on 03/30/26 | ||
| High | 6.79 on 10/16/25 | 9.94 on 03/10/26 | 5.45 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +172.35% since 07/29/25 | -1.85% since 12/26/25 | +2.87% since 12/26/25 | ||
| Low | 1.75 on 07/30/25 | 5.73 on 02/20/26 | 3.00 on 02/05/26 | ||
| High | 6.79 on 10/16/25 | 9.94 on 03/10/26 | 5.45 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +470.20% since 04/29/25 | +35.49% since 09/26/25 | +9.82% since 09/26/25 | ||
| Low | 0.81 on 04/30/25 | 4.27 on 11/07/25 | 2.81 on 11/21/25 | ||
| High | 6.79 on 10/16/25 | 9.94 on 03/10/26 | 5.45 on 03/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 378,086 | 393,068 | 375,929 | ||
| Shares Outstanding, K | 81,660 | 59,108 | 109,123 | ||
| Annual Sales | 0 | 216,110,000 | 0 | ||
| Annual Net Income | -22,230,000 | -220,470,000 | -223,120,000 | ||
| Last Quarter Sales | 0 | 57,220,000 | 0 | ||
| Last Quarter Net Income | -5,500,000 | -141,190,000 | -42,540,000 | ||
| 60-Month Beta | 1.45 | 0.55 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 08/20/25 | -0.46 on 02/11/26 | -0.38 on 02/26/26 | ||
| Latest Earnings Date | 11/13/25 | 05/06/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||